PE-Backed Biz Interrupts $425M Merger Of Biotech Firms
Jounce Therapeutics Inc. said on Wednesday that it has received an unsolicited offer from an affiliate of a private equity firm weeks after the U.S. biotechnology company agreed to merge with British...To view the full article, register now.
Already a subscriber? Click here to view full article